NDC 59417-105-10
Vyvanse 50 mg/1
lisdexamfetamine dimesylate · CAPSULE
Vyvanse is a capsule containing lisdexamfetamine dimesylate at a strength of 50 mg/1. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Vyvanse
- Generic Name
- lisdexamfetamine dimesylate
- NDC Code (Package)
59417-105-10- NDC Code (Product)
59417-105- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 50 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA021977
- Marketing Start
- 02/23/2007
Recall History
No Recall HistoryView Full Drug Page
Vyvanse — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.